Western Cell Therapy

1. Review current and emerging cellular therapy indications, eligibility criteria, and treatment pathways for patients with hematologic malignancies, including multiple myeloma, lymphoma,
2. Identify appropriate patients for cellular therapy evaluation and referral by applying current evidence, patient selection criteria, and best practices for care coordination across academic, community, and rural practice settings.
3. Implement strategies to improve access to and delivery of cellular therapy services through effective collaboration among referring providers, academic centers, and multidisciplinary care teams, ultimately enhancing patient outcomes and timely access to treatment.

AMA Statement: The University of Utah School of Medicine designates this Live Activity for a maximum of 8.50 AMA PRA Category 1 Credit(s)^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Passport: The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit.  Visit www.cmepassport.org to create and view your account.  

All can use this system: All activity attendees are encouraged to use the CloudCME system to claim their attendance.  Physicians will be awarded AMA PRA Category 1 Credit(s)TM. All other professions will be awarded attendance at a CME that they may use for their re-credentialing purposes.  All users will be able to print or save certificates and transcripts.  For questions regarding CME or CloudCME, please contact the UUCME Office.  For questions regarding re-credentialing process of requirements, please contact your re-credentialing organization.

Nondiscrimination and Disability Accommodation Statement:  The University of Utah does not discriminate on the basis of race, ethnicity, color, religion, national origin, sex, pregnancy, pregnancy-related conditions, age, disability, sexual orientation, gender identity, gender expression, genetic information or protected veteran’s status, in employment, treatment, admission, access to educational programs and activities, or other University benefits or services. Additionally, the University endeavors to provide reasonable accommodations and to ensure equal access to qualified persons with disabilities. Inquiries or complaints about University nondiscrimination and disability/access policies may be directed to the Director, OEO/AA, Title IX/Section 504/ADA Coordinator, 383 University Street, Level One OEO Suite, Salt Lake City, UT 84112, 801-581-8365 (Voice/TTY), 801-585-5746 (Fax).

Welcome to the University of Utah Health CME Portal! 
The University of Utah Health CME team is here to help!

Mitigation of Relevant Financial Relationships

The University of Utah School of Medicine Continuing Medical Education Office (UUCME) meets ACCME Standards for Integrity and Independence expectations regarding the identification and mitigation of relevant financial relationships with ACCME-defined ineligible companies. Everyone in control of content, including all speakers and planners, must disclose financial relationships with ineligible companies in any amount within the past 24 months and all relevant financial relationships have been mitigated prior to the activity start.

Disclosure: Neither planners, speakers, or anyone in control of content have any relevant financial relationships with an ACCME-defined ineligible company to disclose with the exception of  those listed below. All relevant financial relationships have been mitigated.

• Novartis

• Syndax

• Sebia

• JnJ

• BMS

• Umoja

• Lyell 

• Kite Pharma

• Kyverna